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Abstract: Beyond the role of 17β-estradiol (E2) in reproduction and during the menstrual 
cycle, it has been shown to modulate numerous physiological processes such as cell 
proliferation, apoptosis, inflammation and ion transport in many tissues. The pathways in 
which estrogens affect an organism have been partially described, although many questions 
still exist regarding estrogens’ interaction with biomacromolecules. Hence, the present 
study showed the interaction of four oligonucleotides (17, 20, 24 and/or 38-mer) with E2. 
The strength of these interactions was evaluated using optical methods, showing that  
the interaction is influenced by three major factors, namely: oligonucleotide length,  
E2 concentration and interaction time. In addition, the denaturation phenomenon of DNA 
revealed that the binding of E2 leads to destabilization of hydrogen bonds between the 
nitrogenous bases of DNA strands resulting in a decrease of their melting temperatures 
(Tm). To obtain a more detailed insight into these interactions, MALDI-TOF mass 
spectrometry was employed. This study revealed that E2 with DNA forms non-covalent 
OPEN ACCESS 
Int. J. Environ. Res. Public Health 2014, 11 7726 
 
 
physical complexes, observed as the mass shifts for app. 270 Da (Mr of E2) to  
higher molecular masses. Taken together, our results indicate that E2 can affect 
biomacromolecules, as circulating oligonucleotides, which can trigger mutations, leading 
to various unwanted effects. 
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1. Introduction 
Contaminants of emerging concern (CECs), such as endocrine disrupting compounds (EDCs),  
are organic contaminants that have been detected in wastewater, surface water, and drinking water 
throughout the world [1–4]. Among the EDCs, estrogen hormones have become emerging pollutants, 
because of their presence in various environmental compartments and concerns about their estrogenic 
effects to wildlife and humans [5–7]. Humans can be exposed to estrogens on a daily basis, especially 
because of their presence in drinking water [4]. The increased exposure of estrogen hormones, among 
which the largest potency is dedicated to 17β-estradiol (E2) [8–10], may cause abnormal reproduction, 
dysfunctions of neuronal and immune systems, or stimulation of cancer cells proliferation [11–14]. 
Currently, more than 70% of breast carcinomas are found to be estrogen receptor positive (ER+) [15], 
exhibiting the positive proliferative effects as a response to the presence of estrogens [16,17]. 
Although estrogen exposure is now a widely accepted risk factor in breast cancer development,  
the mechanisms through which estrogens induce breast carcinogenesis have not been described 
satisfactorily. One of the generally accepted mechanisms includes metabolism of E2 via cytochrome 
P450-mediated oxidation of catechol estrogens to quinones that react with DNA and form  
estrogen-DNA adducts. The resulting critical mutations can trigger the development of breast and also 
other human malignancies [18,19]. Estrogens may further affect cell proliferation via several genomic 
and non-genomic pathways [20,21]. The mechanisms of genomic signaling of estrogens have been 
reported by several researchers [22–26] (shown in Figure 1A,B), whereas the non-genomic 
mechanisms are still not well understood (shown in Figure 1C,D). The most likely hypothesis seems to 
be the activation of signaling cascades via second messenger as cAMP [27], which subsequently 
initiates the action of protein kinase A, or mobilize the intracellular calcium in a rapid manner [28]. 
Both, models representing genomic and non-genomic signaling pathways are shown in Figure 1A–D.  
Whereas several actions of E2 are caused by its reactive metabolites, there exist also possible 
effects, resulting from excessive exposure to unmetabolized E2 per se. Hence, the aim of this study is 
to identify the possible interactions between 17β-estradiol, the most potent natural estrogen, and 
double-stranded DNA, the key macromolecule reacting with carcinogens. We suggested four dsDNA 
fragments imitating short sections of the natural DNA sequences comprising estrogen response 
elements (ERE) as the promoter regions for estrogen-driven transcription [29]. DNA fragments  
are found to be varied in their length and nitrogenous bases composition. After interactions with E2, 
their behavior was observed using UV-vis spectrophotometry and matrix-assisted laser 
desorption/ionization time of flight (MALDI-TOF) mass spectrometry in a timely manner. 
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Figure 1. Model expressing the distinct molecular pathways of ER transcription factors 
regulatory actions. (A) The classical direct, genomic ligand-dependent pathway includes 
detachment of transcription factors—Estrogen receptors (ER) from complex with heat 
shock proteins (HSP) and shift of E2-ER complex towards estrogen response element 
(ERE), localized in nucleus, where transcription is triggered after recruitment of 
coactivators (CoA) and corepressors (CoR) of transcription process [24]. (B) Non-direct 
genomic ligand-dependent mechanism—Tethering or cross-talk includes protein-protein 
interaction with other transcription factors (TF) after ligand activation, and thereby gene 
regulation is affected by indirect DNA binding [29]. (C) Estrogen receptors can be 
phosphorylated at specific serine sites by growth factors (GF) and other plasma membrane 
estrogen receptors, coupled to kinase signaling (ERK-extracellular regulated kinase,  
Akt—Protein kinase B, PI3K—Phosphoinositide 3-kinase). Phosphorylated (P) ER can 
trigger the transcription in a ligand-independent manner [26]. (D) The non-genomic effect 
includes the activation of receptor, associated with the membrane receptors including  
G-protein-coupled receptor (GPER). Signaling through GPER occurs via transactivation of 
the epidermal growth factor receptor (EGFR) activated by metalloproteinases (MMP).  
This phenomenon leads to downstream activation of various signaling molecules, 
triggering possible alterations in protein synthesis. Furthermore, cyclic adenosine 
monophosphate (cAMP) and intracellular calcium mobilization (Ca
++
) are stimulated by 
E2-mediated activation of GPER. This leads to rapid physiological responses without gene 
regulation. Moreover, GPER also regulates transcriptional activity by other signaling 
mechanisms as cAMP, ERK or PI3K [27]. 
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2. Experimental Section 
2.1. Chemicals and pH Measurement 
Working solutions as buffers or standard solution of 17β-estradiol were prepared daily by diluting 
the stock solutions. The interactions of E2 and DNA fragments were carried out in the environment 
maintained by phosphate buffered saline (PBS, pH = 7.4), whose osmolarity and ion concentrations 
match with those of the isotonic environment in human body. PBS was prepared according to the 
protocol as follows: 8.01 g∙L
−1
 of NaCl, 0.20 g∙L
−1
 of KCl; 1.78 g∙L
−1
 of Na2HPO4·H2O and 0.27 g∙L
−1
 
of KH2PO4, dissolved MilliQ water, obtained by reverse osmosis using Aqual 25 (Aqual s.r.o., Brno, 
Czech Republic). The water was purified by apparatus Direct-Q 3 UV Water Purification System 
equipped with the UV lamp, purchased from Millipore (Billerica, MA, USA) with resistance 
established to 18 MΩ·cm
−1
. 17β-estradiol, oligonucleotides and others were purchased from Sigma 
Aldrich (St. Louis, MO, USA) in ACS purity, unless noted otherwise. The pH was measured using pH 
meter WTW inoLab (Weilheim, Germany). 
2.2. Oligonucleotides 
Sequences used for experiments were designed as it is shown in Table 1. 













2.3. The Hybridization Process of Single-Stranded DNA Fragments 
The double-stranded DNA fragments were acquired by hybridization of two complementary  
single-stranded DNA oligonucleotides in ratio 1:1, with volume of 30 µL. Subsequently, 30 µL of 
immobilization solution (composed of 100 mM Na2HPO4 + 100 mM NaH2PO4), 0.5 M NaCl, 0.6 M 
guanidinium thiocyanate, 0.15 M Trizma base adjusted by HCl on pH of 7.5 was added to the solution 
containing oligonucleotides. The resulting solution was stirred for 40 min to obtain the final  
dsDNA fragments. 
2.4. Spectrophotometric Analysis of Interactions between E2 and DNA Fragments 
Two hundred µL of mixture, comprising E2 (final concentrations in range 0, 0.625. 1.25, 2.5, 5, 10, 
20 and 40 nM) and oligonucleotides representing EREs (final concentration of 200 nM) was analyzed 
using UV-vis spectrophotometer SPECORD 210 (Analytik Jena, Jena, Germany). Prior to each 
measurement, the resulting complex was filtered through Amicon 3k (Millipore, Billerica, MA, USA). 
Int. J. Environ. Res. Public Health 2014, 11 7729 
 
 
Carousel was heated to 37 °C by a flow thermostat Julabo F25 (Julabo, Seelbach, Germany) and the 
absorption characteristics of DNA representing EREs (Aλmax = 260 nm) were determined during 0–120 min 
lasting of interaction. For the subsequent denaturation study, the same final concentrations of E2  
(0–40 nM) and DNA (200 nM) were employed. The denaturation study was carried out within the 
temperature ranges from 25 to 80 °C per 1.5 °C every 90 s using UV-vis spectrophotometer 
SPECORD S600 (Analytik Jena, Jena, Germany) by measuring of absorption maxima of DNA as 
Aλmax = 260 nm. Denaturation analyses were carried out with E2/DNA mixture after 120 min of  
lasting interaction. 
2.5. MALDI-TOF MS Analysis of E2/DNA Fragments Interaction 
Interaction of each ERE oligonucleotide in final concentration of 50 nM with E2 in final 
concentration of 20 nM was analyzed using matrix assisted laser desorption/ionization-time of flight 
(MALDI-TOF) mass spectrometer Bruker Ultraflextreme (Bruker Daltonik GmbH, Germany) 
equipped with a laser at the wavelength of 355 nm with an accelerating voltage of 25 kV, cooled with 
nitrogen. Prior each measurement, the resulting complex was filtered through Amicon 3k (Millipore, 
Billerica, MA, USA). The matrix used for the analyses was 3-hydroxypicolinic acid (3-HPA) with 
addition of ammonium citrate (0.8 mg in 100 µL of water). The solutions for analyses were mixed in 
ratio of 1:1 (matrix/substance). After obtaining a homogeneous solution, 1 µL was applied on the 
target and dried under atmospheric pressure and ambient temperature (25 °C). The spectra were 
typically acquired from the average of 20 sub spectra from a total of 500 shots of the laser. 
2.6. Descriptive Statistics 





 and Microsoft PowerPoint
®
 (Microsoft, Redmond, WA, USA). Results are 
expressed as mean ± standard deviation (S.D.) unless noted otherwise. 
3. Results and Discussion 
On the basis of cellular functions, DNA is the key macromolecule, which is highly protected against 
damages coming from various substances including those called carcinogens [30,31]. Metabolism of 
estrogens via catechol estrogen pathway was previously characterized as a balanced set of activating 
and protective enzymes. The disruption of this homeostasis with excessive production of catechol 
estrogen quinones leads to interactions with DNA molecules resulting in inducement of mutagenesis 
and subsequent initiation of breast cancer [32]. Due to the fact that the metabolic conversion of  
E2 plays a crucial role in its adverse effects on organisms, there may exist other ways how the estrogen 
hormones (among which E2 exhibits the largest potency [10]) affect macromolecules as the nucleic 
acids. Therefore, for a better understanding of the fate of DNA upon contact with E2, we decided to 
perform an in vitro interaction study using spectrophotometry and mass spectrometry. 
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3.1. An Optical Behavior of DNA Affected by 17β-Estradiol 
Firstly, UV-vis spectrophotometry was employed to study 17β-estradiol interactions with DNA  
on the level of basic in vitro characteristics. To determine the interaction strength, the changes of  
DNA absorbance (final concentration 200 nM) at Aλmax = 260 nm after interactions with E2 (final 
concentrations in range 0–40 nM) were evaluated. As it is obvious from curves in Figure 2Aa–Da, 
shorter oligonucleotides were determined to exhibit weaker interaction in time, but 120 min were 
shown to be sufficient to change the optical attributes of all tested sequences of DNA. Subsequently,  
to better understand the obtained results, the DNA absorbance was converted into bar graphs. In these 
figures, the largest applied concentrations of E2 (40 nM) were presented for whole interaction interval. 
The shortest chain (17-mer) was shown to interact weakly. The most significant change in optical 
behavior was identified after 120 min (0.37 AU compared with absorbance of control—0 nM  
E2—0.82 AU) as it is shown in Figure 2Ab. In the case of longer sequences, more apparent decrease of 
their absorbance occurs after 120 min, particularly to the final 0.26 AU in DNA composed of 20 bp  
(Figure 2Bb), to 0.21 AU in DNA composed of 24 bp (Figure 2Cb) and 0.18 AU in the longest DNA 
composed of 38 bp (Figure 2Db). 
Figure 2. The expression of the interaction strength between DNA fragment and  
E2 obtained using UV-vis spectrophotometry. Various interaction times were tested  
(0–120 min), and influence of E2 (final concentrations used as 0, 0.625, 1.25, 2.5, 5, 10, 20 and 
40 nM) on DNA fragment (200 nM) absorbance was determined at DNA absorption 
maxima (Aλmax = 260 nm). (A) ERE1, composed of 17 bp; (B) ERE2—20 bp;  
(C) ERE3—24 bp; (D) ERE4—38 bp. The shown absorbance values of 40 nM E2 in entire 
interaction time period (0–120 h) were marked with lowercase. (Ab) ERE1, (Bb) ERE2, 
(Cb) ERE3 and (Db) ERE4. The values are means of three independent replicates (n = 3). 
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It can be concluded, based on the obtained results, that within the time interval of 0–120 min,  
the interactions are fundamentally dependent on the three factors (I) oligonucleotide length; (II) time 
of interaction and (III) concentration of E2. Particularly, the longer DNA sequences provide more 
accessible binding sites for hormone interaction, which then results in formation of the complex under 
lower threshold concentrations and moreover, a shorter time is required for its establishment. Because 
nucleic acids absorb strongly in the UV region (260 nm) [33], the hypochromic effect under the 
influence of E2 is caused by changing of optical behavior of the complex, but not by disintegration of 
double-stranded structure that commonly leads to the increase of absorbance by unstacking of 
nitrogenous bases elevating absorbance of single-stranded DNA [34]. 
3.2. An Effect of 17β-Estradiol on Denaturation of Double-Stranded DNA 
Differences in energy between stacked G·C and A·T Watson-Crick base pairs in DNA duplex lead 
to complex melting profiles, observable with optical methods, providing a high degree of precision for 
the evaluation of thermodynamic quantities associated with the DNA stability [35]. Therefore,  
we decided to determine this DNA denaturation phenomenon using UV-vis spectrophotometry.  
In accordance with previous spectrophotometric results, we confirmed that the length of nucleic acid is 
closely related to willingness of the complexes formation. As it is shown in Figure 3A, melting 
temperature (Tm) of the shortest DNA sequence (ERE1) exhibited Tm disparity at about 3.5 °C 
(subtraction of DNA +40 nM E2 from DNA with no E2 application after 120 min of lasting interaction). 
Despite the fact that in preliminary experiments, it was determined that 120 min of interaction are 
sufficient to form complex, and it was shown that the formation of the complex effect on the structure 
of ERE1 with 17-mer is not seen. This phenomenon points to a higher stability of shorter sequences 
against E2 and is closely related to sequence, where A·T pair is held by only two hydrogen bonds, 
while G·C has three, as it was described previously [36]. With increasing chain length, larger 
disparities between control and the highest applied E2 concentration (40 nM) were observed. As it can 
be seen in Figure 3B, in 20-mer ERE2 was observed 9 °C difference in Tm. In case of 24-mer ERE3 the 
difference in Tm reached 15.3 °C (Figure 3C) and finally in 38-mer ERE4 22.3 °C difference was 
determined (Figure 3D). Such a big melting abnormality is caused by a physical complexation of 
hormone with DNA, which leads to destabilization of the hydrogen bonds between the nitrogenous 
bases of DNA strands. This phenomenon further causes decrease of Tm, in which the differential 
stability of A·T and G·C base pairs can be altered with a minimum of disturbance of the other 
properties of the native DNA helix [37]. 
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Figure 3. Melting temperatures (range 25–80 °C) of DNA (final concentration 200 nM) 
were evaluated after interaction with 17β-estradiol in final concentrations in range 0, 0.625, 
1.25, 2.5, 5, 10, 20 and 40 nM and denaturation phenomenon is shown for: (A) ERE1;  
(B) for ERE2; (C) for ERE3; and (D) for ERE4 (interaction time—120 min, temperature 
increase step of 1.5 °C per 90 s). Absorbance was determined in Aλmax of DNA = 260 nm. 
The values are means of three independent replicates (n = 3). 
 
3.3. MALDI-TOF Mass Spectrometry for Evaluation of E2-DNA Interaction 
To confirm the DNA/hormone complex formation, the MALDI-TOF analyses were carried out 
(Figure 4A–D). 3-hydroxypicolinic acid (3-HPA) which is commonly used as a DNA specific matrix 
was employed in this experiment [38–40]. Due to the presence of the negatively charged phosphate 




) is often observed in spectra of 
DNA. Hence a matrix additive represented by ammonium citrate was used to suppress undesirable 




 ions, which are complexed with 
citrate [41]. The results of control analyses point to denaturation of double-stranded DNA. This 
phenomenon is caused by 3-HPA matrix as it was described previously, and results from protonation 
of bases that destabilize hydrogen bonds between two strands that partially denature a duplex upon 
mixing with 3-HPA [42]. Moreover, in the case of ERE2 and ERE3 control measurements, depurinating 
products, occurred as a result of heating (ionization with laser) and formed typical secondary peaks 
having 151 mass units (in the case of dG) less than major peak [43], which it is shown in Figure 4B,C.  
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It was also shown that alkali metal adducts are completely absent in DNA spectra; thus, the ammonium 
citrate co-matrix performs well to eliminate them. 
Figure 4. The matrix-assisted laser desorption/ionization time of flight (MALDI-TOF) 
mass spectra show the way of interaction between E2 (final concentration 20 nM) and each 
of DNA fragments (final concentration 50 nM) after 120 min. Spectra were carried out in 
linear, positive mode, using 3-hydroxypicolinic acid (3-HPA) as the matrix and laser 
output of 70%. The spectra show complex formation with (A) ERE1; (B) ERE2; (C) ERE3 
and (D) ERE4. Upper spectra always show both—Calculated (MwODNcal) and 
experimentally determined molecular weight of DNA fragments. The lower spectra show 
the formation of complexes upon interaction with 20 nM E2. 
 
Subsequently, the interactions of DNA with 20 nM E2 were carried out and lasted 120 min. As it is 
shown in lower spectra in Figure 4A–D, all oligonucleotides formed complexes shifting by app.  
270 Da (Mr of E2) to higher molecular masses. Moreover, the reduction of signal intensity and mass 
resolution occurred while increased the spectra complexity. This phenomenon is typical for 
oligonucleotides when forming the complexes [44]. Although both the purine and pyrimidine bases 
make up the structure of DNA contain nucleophilic sites suitable for reaction with carcinogens,  
the purines (adenine and guanine) are usually the most reactive sites for reaction [45]. Nevertheless, 
the metabolic conversion to reactive catechol estrogen quinones is fundamental for covalent interaction 
by Michael addition that results in depurinating adducts [18,46]. 
In organisms, the loss of these depurinating adducts generates apurinic sites and results in mutations 
in the H-ras oncogene by error-prone repair and subsequent mutations in H-ras protein that directs 
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cells to grow and divide without control [47]. Moreover, the formation of covalent adducts with 
genotoxic carcinogens does not happen with DNA only, but also with all cellular nucleophilic species, e.g., 
protein, glutathione and/or water [48], but with not so profound genetic consequences as that on DNA. 
Our in vitro study shows that excessive amount of E2 exhibits a potential to form the complexes 
with nucleic acids, and thus affect their attributes, which result in various pathological phenomena, 
with no need of conversion via cytochrome P450 pathway to more reactive products. Due to the fact 
that E2 is not chemically reactive, the strong complexes arise as a consequence of non-covalent 
physical reaction as it has been previously demonstrated by Saeed and coworkers with synthetic 
estrogen diethylstilbestrol (DES) [49]. Hendry and colleagues employed computational approach and 
they demonstrated that in partially unwound DNA there can be accommodated a variety of small 
molecules [50]. Estradiol was shown to be hypothetically inserted between base pair in DNA, using its 
hydroxyl groups at 3- and 17β-positions to form hydrogen bonds to phosphate oxygens on adjacent 
strands of DNA, because E2 contains heteroatoms separated by internuclear distances similar to that of 
phosphate oxygens on strands of dsDNA [51]. Based on our results, it can be stated that estradiol fits 
well within the topography of the double-helix molecule of DNA and physical complexes that can 
potentially affect the physiological behavior of the DNA and may form essential precursors for 
covalent bonds being formed between DNA and reactive estrogen metabolites. 
Because of steroidal hormone properties, estrogens may pass through the phospholipid membranes 
of the cell to accomplish the interactions with circulating nucleotides as miRNA and/or siRNA to 
disturb their physiological functions. The RNA is not complexed with histones or embedded in 
chromatin structure, hence nucleotides are particularly sensitive to the binding of genotoxic agents of 
environmental origin [52]. It is conceivable that environmental carcinogens may modify the structure 
of miRNAs, thus blocking their access to the catalytic pockets of Dicers and arresting the miRNA 
maturation process. However, in the case of E2 complexes with these molecules, the real biological 
significance has to be elucidated through further, comprehensive in vivo experiments. 
4. Conclusions 
In our study, we showed that increased levels of hormone 17β-estradiol (E2) exhibit the potential to 
form complexes directly with double-stranded DNA. Using spectrophotometry and mass spectrometry 
it was shown that three major factors crucially influence the interaction: (I) the complexes were 
observed earlier if higher E2 concentration was used; (II) on the other hand increased time of 
interaction was shown to require lower concentrations of hormone to form complexes; and (III) it was 
revealed that longer oligonucleotide sequences form complex more readily probably due to higher 
content of E2 binding sites in their sequences. The stability of longer oligonucleotides was shown to be 
more influenced by hormone, probably due to a higher amount of binding sites causing destabilization 
of hydrogen bonds in DNA strands. Finally, the formation of the complexes was revealed by mass 
spectrometry MALDI-TOF, where shifts by about 272.38 Da were observed, pointing to the ability of 
E2 to bind the DNA and form the strong complexes as a result of non-covalent physical interaction, 
changing the optical and spectrometrical attributes of DNA. 
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